GlassScriptPhysician profile
Deepak K Jain
NPI 1356368823
$13,034.26
in general payments reported to CMS, 2019-2025
57 companies · $1,676 in 2025
The $1,676 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,557 · 2020: $4,343 · 2021: $1,314 · 2022: $1,036 · 2023: $1,353 · 2024: $1,755 · 2025: $1,676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,784.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $3,960.00 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $2,338.83 | 2019-2025 | Farxiga, Tezspire, Breztri |
| Novo Nordisk INC | $809.69 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $529.62 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $366.82 | 2021-2025 | |
| Glaxosmithkline, LLC. | $365.24 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $360.70 | 2019-2025 | Jardiance |
| Pfizer INC. | $334.96 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $320.94 | 2019-2022 | |
| Shockwave Medical, INC | $288.05 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Eisai INC. | $286.45 | 2021-2025 | |
| Exact Sciences Corporation | $249.28 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $208.04 | 2022-2025 | Repatha, Otezla, Otezla |
| Mannkind Corporation | $196.47 | 2019-2024 | |
| Daiichi Sankyo INC. | $190.49 | 2019-2024 | Injectafer |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.